JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265081

Human ADCY7 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ADCY7 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 10 bp deletion in exon 4.

View Alternative Names

ATP pyrophosphate-lyase, Adenylyl cyclase, KIAA0037, adenylate cyclase 7

1 Images
Sanger Sequencing - Human ADCY7 knockout HeLa cell line (AB265081)
  • Sanger seq

Unknown

Sanger Sequencing - Human ADCY7 knockout HeLa cell line (AB265081)

Homozygous : 10 bp deletion in exon 4.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 10 bp deletion in exon 4

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265081-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265081 Human ADCY7 knockout HeLa cell line", "number":"AB265081-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265081-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265081 Human ADCY7 knockout HeLa cell line", "number":"AB265081-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ADCY7
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ADCY7 also known as Adenylate Cyclase 7 is an enzyme responsible for the conversion of ATP to cyclic AMP (cAMP) an important secondary messenger in cells. This enzyme has a molecular mass of approximately 120 kDa. ADCY7 is expressed mainly in the brain and immune cells such as T cells and B cells. In cellular membranes ADCY7 functions as part of a larger signaling network contributing to the regulation of various cellular processes.
Biological function summary

This enzyme participates in the modulation of intracellular signaling pathways by altering cAMP levels. ADCY7 does not usually function alone; it interacts with other signaling molecules forming complexes that influence cellular responses. By regulating cAMP levels ADCY7 can affect processes like cell proliferation differentiation and immune responses.

Pathways

Adenylate cyclase activity of ADCY7 plays a significant role in G protein-coupled receptor (GPCR) signaling and is involved in the downstream cAMP signaling pathway. These pathways are critical for transmitting signals from extracellular stimuli to intracellular effectors. ADCY7 interacts with G proteins which directly influence its activity. It is also associated with pathways including the MAPK signaling involving a chain of proteins in the cell that communicates signals from receptors on the cell surface to the DNA in the nucleus.

Changes in ADCY7 function are linked to both immune and neurological conditions. For example aberrant ADCY7 signaling has been associated with mood disorders such as depression. Additionally abnormalities in its regulation could influence autoimmune disorders due to its expression in immune cells. ADCY7 connects to other proteins implicated in these conditions like G proteins which are involved in modifying immune and neurotransmitter receptor activities.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com